This article was originally published in The Gray Sheet
Executive SummaryPresident and CEO Nick Teti is elected chairman, firm announces July 23. Teti will take over for Richard Babbitt, who will remain a member of the board through year-end and will then serve the firm in an advisory capacity. Teti has served as president and CEO since July 2001 (1"The Gray Sheet" July 16, 2001, In Brief)...
You may also be interested in...
Senate Finance Committee’s approach to penalize companies for raising WAC list prices is not a ‘price control,’ but a reasonable approach to change the incentives that distort pricing in the supply chain, US HHS Secretary Alex Azar says.
With the pre-GDUFA backlog largely acted upon, the FDA expects ANDA approvals to decrease, but supplement actions to increase in FY 2020 and FY 2021.
February and March inspections deferred unless any are deemed mission critical. China director remains behind as staff evacuate.